高良姜素调节皮肤免疫稳态抗黑色素丢失的作用机制研究OA
Mechanism of Galangin in Regulating Skin Immune Homeostasis to Prevent Melanin Loss
目的:探讨高良姜主要活性成分高良姜素抵抗小鼠皮肤色素脱失的作用及机制.方法:体内试验采用咪喹莫特建立小鼠皮肤适应性免疫模型,在造模诱导第2 d小鼠背部涂抹高良姜素乳膏治疗,直至第 7 天.苏木精和伊红(HE)染色检测皮肤组织病理变化;免疫组化(IHC)和免疫荧光(IF)测定F4/80、CD68 和CD8+T的水平;流式细胞术检测小鼠脾脏与外周血中的T细胞亚群.体外试验采用脂多糖(LPS)建立RAW264.7 细胞炎症模型.收集LPS刺激并给药处理后的RAW264.7 细胞培养上清,与B16F10 细胞共培养,测定B16F10 细胞活力、黑色素含量、酪氨酸酶活力和活性氧(ROS)水平;RT-qPCR法测定炎症细胞因子的mRNA表达.结果:与正常对照组比较,模型对照组小鼠红斑数量增加,黑色素百分率降低(P<0.05),F4/80、CD68 和CD8+T水平明显增加(P<0.05),脾脏CD45+T下降,脾外周血CD45+T升高,CD3+T/CD45+T和CD3+、CD8+T/CD45+T降低(P<0.05);与模型对照组相比较,高良姜素40 mg/kg小鼠的皮肤红斑数量减少,皮肤黑色素百分率升高(P<0.05),F4/80、CD68 和CD8+T水平降低(P<0.05),脾脏CD45+T比例明显增加,外周血CD45+T降低,CD3+T/CD45+T和CD3+,CD8+T/CD45+T降低(P<0.05).在细胞水平,与空白对照组相比较,LPS诱导RAW264.7 细胞炎症因子Il1b、Inos和Il6 mRNA表达上调,B16F10 细胞的活力、黑色素含量以及酪氨酸酶活力降低;与模型对照组相比较,高良姜素0.01 mol/L组RAW264.7 细胞炎症因子Il1b、Inos和Il6 mRNA的表达下调,黑色素细胞活力、黑色素含量、酪氨酸酶活力升高(P<0.05),活性氧(ROS)水平降低.结论:高良姜素可能通过抑制Inos等炎症因子的表达,恢复炎症介导的免疫稳态,抵抗T细胞对黑色素细胞的损伤,进而抵抗黑色素的丢失.
Objective:To investigate the mechanism by which galangin,the primary active ingredient of traditional Chinese medicine(TCM)Alpiniae Officinarum Rhizoma,prevents skin depigmentation in mice.Methods:In vivo,imi-quimod(IMQ)was used to establish an adaptive immune model of mouse skin,and galangin cream was applied on the mice's back from day 2 of induction until day 7.Hematoxylin-eosin(HE)staining was used to detect pathological chan-ges in the skin tissue,while immunohistochemistry(IHC)and immunofluorescence(IF)were used to assess the expres-sion levels of F4/80,CD68,and CD8+T cells.Flow cytometry was employed to detect T cell subsets in the spleen and peripheral blood of mice.In vitro,lipopolysaccharide(LPS)was used to induce an inflammatory model of RAW264.7 cells.The culture supernatant of LPS-stimulated RAW264.7 cells treated with galangin was collected and co-cultured with B16F10 cells to measure B16F10 cell viability,melanin content,tyrosinase activity,and reactive oxygen species(ROS)levels,and the mRNA expression of inflammatory cytokines was determined by RT-qPCR.Results:Compared with those in the normal control group,mice in model control group exhibited a significantly increased number of erythe-ma,decreased percentage of melanin(P<0.05),and increased number of macrophages,CD68,and CD8+T cells(P<0.05),decreased CD45+T cells in the spleen,and increased CD45+T cells in peripheral blood.Meanwhile,the ratios of CD3+T/CD45+T cells and CD3+,CD8+T cells/CD4+T cells were downregulated(P<0.05).Compared with those in the model group,mice treated with galangin at a dose of 40 mg/kg showed a significantly decreased number of erythema,increased percentage of melanin(P<0.05),and decreased number of macrophages,CD68,and CD8+T cells in the skin(P<0.05),significantly increased proportion of CD45+T cells in the spleen,decreased CD45+T cells in peripheral blood,and reduced ratios of CD3+T/CD4+T cells and CD3+,CD8+T cells/CD45+T cells(P<0.05).At the cellular level,compared with those in the blank control group,the mRNA expression levels of inflammatory cytokines Il1β,iNos,and Il6 in LPS-stimulated RAW264.7 cells were significantly upregulated.Co-culture with B16F10 cells showed reduced B16F10 cell viability,melanin content,and tyrosinase activity.Compared with those in the model group,the mRNA ex-pression levels of inflammatory cytokines Il1β,iNos,and Il6 in 0.01 mmol/L galangin-treated RAW264.7 cells were downregulated.Increased cell viability,melanin content,and tyrosinase activity of melanocytes(P<0.05),and decreased ROS levels were also observed(P<0.05).Conclusion:Galangin may improve inflammation-mediated immune homeo-stasis by inhibiting the expression of inflammatory cytokines such as iNOS,thereby protecting melanocytes from T-cell-mediated damage,and ultimately preventing the loss of melanin.
魏文婧;徐登球;阿卜杜热伊木·阿力木江;赵竟成;霍仕霞;李治建
石河子大学药学院,新疆植物药资源与利用教育部重点实验室,石河子 832002安徽省肿瘤免疫微环境与免疫治疗重点实验室,合肥/安徽医科大学第一附属医院,合肥 230022新疆维吾尔自治区维吾尔医医院,乌鲁木齐 830049||新疆中药医院制剂循证与转化重点实验室,乌鲁木齐 830049新疆维吾尔自治区维吾尔医医院,乌鲁木齐 830049||新疆中药医院制剂循证与转化重点实验室,乌鲁木齐 830049新疆维吾尔自治区维吾尔医医院,乌鲁木齐 830049||新疆中药医院制剂循证与转化重点实验室,乌鲁木齐 830049石河子大学药学院,新疆植物药资源与利用教育部重点实验室,石河子 832002||新疆维吾尔自治区维吾尔医医院,乌鲁木齐 830049||新疆中药医院制剂循证与转化重点实验室,乌鲁木齐 830049
高良姜素免疫稳态巨噬细胞黑色素细胞活性氧白介素1β一氧化氮合酶
GalanginImmune homeostasisMacrophageMelanocyteROSIL-1βiNOS
《中药药理与临床》 2026 (1)
61-67,7
国家自然科学基金地区科学基金资助项目(编号:82160821)天山创新团队项目(编号:2024D14018)自治区青年岐黄(霍仕霞).
评论